Home > Insider Trading > Filing (0001209191-21-018435)

Filing Details

Accession Number:: 0001209191-21-018435
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-05 20:56:18
Reporting Period:: 2021-03-04

Accepted Time:: 2021-03-05 20:56:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1595893	Turning Point Therapeutics Inc.	TPTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1351888	Siegfried Reich	C/O Turning Point Therapeutics, Inc. 10628 Science Center Drive, Ste. 200 San Diego CA 92121	Evp & Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-03-04	35,550	$51.28	39,395	No	4	M	Direct
Common Stock	Disposition	2021-03-04	3,005	$102.01	36,390	No	4	S	Direct
Common Stock	Disposition	2021-03-04	8,820	$102.87	27,570	No	4	S	Direct
Common Stock	Disposition	2021-03-04	6,220	$103.65	21,350	No	4	S	Direct
Common Stock	Disposition	2021-03-04	2,000	$104.97	19,350	No	4	S	Direct
Common Stock	Disposition	2021-03-04	3,103	$105.71	16,247	No	4	S	Direct
Common Stock	Disposition	2021-03-04	6,716	$107.13	9,531	No	4	S	Direct
Common Stock	Disposition	2021-03-04	3,679	$107.85	5,852	No	4	S	Direct
Common Stock	Disposition	2021-03-04	707	$108.92	5,145	No	4	S	Direct
Common Stock	Disposition	2021-03-04	700	$110.59	4,445	No	4	S	Direct
Common Stock	Disposition	2021-03-04	600	$111.46	3,845	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-03-04	35,550	$0.00	35,550	$51.28

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
114,450		2030-03-01	No	4	M	Direct

Footnotes

Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 23, 2020.
The weighted average sale price for the transaction reported was $102.01, and the range of prices were between $101.37 and $102.32. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $102.87, and the range of prices were between $102.38 and $103.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $103.65, and the range of prices were between $103.40 and $104.20. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $104.97, and the range of prices were between $104.46 and $105.46. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $105.71, and the range of prices were between $105.47 and $106.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $107.13, and the range of prices were between $106.53 and $107.53. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $107.85, and the range of prices were between $107.54 and $108.42. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $108.92, and the range of prices were between $108.75 and $109.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $110.59, and the range of prices were between $110.05 and $110.96. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
The weighted average sale price for the transaction reported was $111.46, and the range of prices were between $111.20 and $111.96. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
25% of the shares vested on March 2, 2021 and 1/48th of the shares vest monthly thereafter over the next three years.